alexa Traditional Ayurvedic medicines: Pathway to develop anti-cancer drugs
ISSN: 2329-9053
Journal of Molecular Pharmaceutics & Organic Process Research
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business
  • Review Article   
  • J Mol Pharm Org Process Res 2015, Vol 3(3): 130
  • DOI: 10.4172/2329-9053.1000130

Traditional Ayurvedic medicines: Pathway to develop anti-cancer drugs

Murari Bhandari1, Anjaneya S Ravipati2, Narsimha Reddy2 and Sundar R Koyyalamudi3,4*
1School of Chemistry and Molecular Biosciences, University of Queensland, QLD 4072, Australia
2School of Science and Health, Western Sydney University, Locked Bag 1797, Penrith, NSW 2751, Australia
3Institute of Endocrinology and Diabetes, Australia
4Discipline of Paediatrics and Child Health, The Children's Hospital at Westmead, The University of Sydney, Sydney, NSW 2145, Australia
*Corresponding Author: Sundar R Koyyalamudi, Discipline of Paediatrics and Child Health, The Children's Hospital at Westmead, The University of Sydney, NSW 2145, Australia, Tel: +61-2-98453185, Fax: +61-2-98453196, Email: [email protected]

Received Date: Dec 03, 2015 / Accepted Date: Dec 18, 2015 / Published Date: Dec 25, 2015

Abstract

Ayurveda, “life knowledge”, is an ancient Indian traditional medical system, which has been practiced for >5000 years and still in use with the same importance among many cultural tribes in Indian sub-continents. Ayurvedic medicine is a unique holistic approach to treatment where herbal medicines, special diets, yoga and relaxation methods, and lifestyle management are key strategies for curing various chronic diseases like diabetes, cancer, cardiovascular, neurological disorders and many other. Cancer is biologically complex disease, causing local damage and inflammation of cells due to lack of full response in a specific tissue that is responsible to maintain cellular differentiation, survival, proliferation and death. Studies have suggested that bioactive phytochemicals present in Ayurvedic plants (fruits, vegetables and herbs) mediate their effects by inhibiting some of the recently identified inflammatory pathways. Nevertheless, for successful implementation of Ayurvedic principles to drug discovery, major concerns relating to proportion, practicality, safety and drug interactions and possible side effects of newly developed Ayurvedic drugs and formulations need to be addressed. Systematic investigations of Ayurvedic drugs, employing contemporary scientific tools and methods, are expected to lead to the discoveries of major significance. Explorations involving studies of bioactive phytochemicals, their side effects, the specific potential targets and the mechanisms of action would transform this traditional therapeutic approach to standard Ayurvedic drug discovery which would be accepted and embraced by global populations. Current review focuses on the importance of anti-cancer drug discovery from Ayurvedic medicines in the modern context, ongoing improvements and major achievements in the field over the past decade or two.

Keywords: Ayurveda; Harmony; Balance

Introduction

“Ayurveda ” – ayus (life) and veda (science/knowledge) means “the science of life”, has unbroken long history as ancient Indian medicinal system for over five thousand years. Ayurveda is often known as the “Mother of all healing ” [1] that brings harmony and balance in all areas of life including mind, body, spiritual well-being and social welfare of mankind [2].

According to Ayurveda, the primary components of human beings and universe is one or combination of the five basic elements (Panchamahabhutas) [3], namely: Prithvi (earth-the principle of inertia), Ap (water-the principle of cohesion), Teja (fire-the principle of radiance), Vayu (air-the principle of vibration), Akasha (ether-the principle of pervasiveness). These five basic principles form three vital forces called Tridoshas : Vata (maintaining nervous system responsible for cell growth, differentiation, cell death, movement of cells, molecules, nutrients and waste), Pitta (maintaining venous system for chemical reactions in the body including digestion, metabolic process, immunity and temperature control) and Kapha (stream nutrition to the arterial system responsible for structure, growth, and protection) [3].

Physical, mental and physiological features (constitution or Prakriti ) of every individual are distinctly different from one another. In Ayurvedic medical practice, the combination of Tridosha and panchamahabhutas are used to determine the nature (Prakriti ) of an individual, accordingly, the treatments are individualized [3]. For example, alterations in “Pitta dosha ” is allied with inflammatory diseases [4] resulting from weakened organs (Dhatus ), and hence “Rasayanaprayoga ” (immunotherapy) is commonly practiced for rejuvenating the body’s support system [5]. Ayurvedic medicine is a holistic and multidimensional medical system with inbuilt capacity to diagnose and treat various illnesses including chronic diseases such as cardiovascular, neurological, diabetes, cancer and many other diseases.

In the context of Ayurveda, a good health is defined as balanced situation of Tridoshas. Imbalance in these vital forces causes diseases and the specific treatment plan for any particular imbalance is defined and practiced in Ayurveda from vedic era. As illustrated in (Figure 1A).

The treatment modality involves a combination of different approaches including yoga, dietary control, meditation, prayers and other means. However, medicinal herbs received greater prominence than other mode of treatments due to their efficacy and prompt curative properties. Globally, herbs and their derivatives became major component of different traditional medicinal systems to treat diseases. Modern scientific and technological advancements have the potential to transform the traditional knowledge of medicinal plants into modern drugs, as described in (Figure 1 B). Many medicinal plant derived drugs such as aspirin, reserpine, and digitalis are a few examples of therapeutic agents discovered from medicinal plants [6]. However, more systematic and robust research is required to derive full benefits of traditional herbs and to discover effective therapeutic agents for life threatening diseases.

molecular-pharmaceutics-organic-modern-medicine

Figure 1: Interface between Ayurveda and modern medicine. (A) Different therapeutic practices mediated in Ayurveda. (B) The modern drug discovery process from derivation of traditional knowledge on herbs to final approved drug.

Ayurvedic formulations have been the first line of treatment in Indian subcontinent for thousands of years due to their less toxicity and wide acceptability [7]. The emerging chemotherapeutic approaches have hampered the practice of Ayurvedic medicine system during the past couple of decades. This is primarily due to the effectiveness of medicinal herbs on disease symptoms is relatively slower than chemotherapeutic drugs. Apparent success of chemotherapeutic drugs, in the treatment of cancer and other serious diseases, has been masked by their side effects and toxicity which have become major downside. In addition, chemotherapy approaches often are not successful for the treatment of major death causing diseases including cancer. This situation has primarily lead to the renewed interest in complementary therapies as a pathway for finding cure for cancer.

In Ayurveda, Charaka and Sushruta Samhitas define cancer as inflammatory or non-inflammatory swelling often known as Granthi (minor neoplasm) or Arbuda (major neoplasm) [8]. Minor neoplasm is mainly caused by weak Shukra Dhatu (tissue regeneration and cell division) interrelated with imbalanced Kapha and/or Vata Dosha . However, missing coordination amongst all these three vital forces is responsible for unhealthy and maline tridoshic major tumor [9]. In principle, it is caused due to unhealthy lifestyle, such as consumption of unhealthy foods, poor hygiene, or bad habits/addiction, or from physical trauma, causing major discrepancies in Tridoshas (Vata, Pitta , and Kapha ) [10]. Inhibition of the tumoral growth and their destruction is accomplished by making changes in metabolic defects and restoring normal tissue functions by improving lifestyle, known as “Sama Dhatu Parampara” [11].

In modern science, cancer is defined as hyper proliferative disorder that involves damage and inflammation of cells in a specific tissue that is responsible to maintain cellular differentiation, survival, proliferation and death [12]. After cardiovascular diseases, cancer is still the second leading cause of death worldwide worse than AIDS, tuberculosis and malaria. According to World Health Organization (WHO), in the year 2012, total cancer deaths were 8.2 million (~22,000 cancer deaths a day), which means that around 15% of total deaths are caused by cancer alone [13]. It is estimated by 2030, globally 21.7 million new cancer cases may exist and 13 million deaths simply due to the growth and aging of the population [14].

In modern medicine, chemotherapy is the first line treatment method for many types of cancer (especially for metastatic disease) [15]. After a huge investment, intensive and systematic research in drug discovery, there are some useful therapeutic agents in the market that include penicillin [16], temozolomide, carmustin, carboplatin and thalidomide [17]. Biologically, once normal cells get mutated and/or become cancer cells and lose most of the normal regulatory functions and continue to multiply cancer cells which are not seen in normal cells [18]. Thus chemotherapeutic drugs do not work properly on cancer as they are mainly targeted to kill cancer cells but not repair the regulatory function. As a result, the degradation takes place continuously. The disappointment in the use of chemotherapeutic treatments, as expected, is also due to many toxic side effects that occur during and after the treatment [19] which will affect the quality of life of the patient due to the very treatment that is intended to provide relief. As a result, the global community is still looking for an alternative and natural medicine that could cure diseases with least side effects and issues.

Towards these goals, traditional medical systems including Ayurveda, Chinese medicine and European medicine have attracted attention as complementary approaches. Ayurvedic medicinal plants have a special place in the treatment of different types of cancer with established outcomes for thousands of years and hence received particular interest. This review is focused on the discovery of bioactive molecules, ongoing improvements, major achievements, current issues and the areas to be improved in the field of anti-cancer drug development from the vast knowledge of Ayurvedic medicine.

Bioactive molecules from Ayurvedic medicine

Plants produce armoury of secondary metabolites that play a vital role in their biochemical pathways and defence against pests. Taking the advantage of bioactive properties, humans started consuming plant products as neutraceuticals. In Ayurveda treatment practices, diet rich in fruits, vegetables, grains and herbal extracts [20] rich in neutraceuticals are consumed to bring health benefits [21,22]. Traditionally, Ayurvedic medicinal plants are consumed in different forms [7]: chewing, swallowing, applying over the skin, teas, consuming with milk, ghee, honey or other solvents commonly known as “Anupana ” in Ayurveda [23].

To date, more than 25,000 plant-based formulations and individual herbs are used in folk and traditional medicine in India by more than 387 thousand qualified practitioners of traditional medicinal system [24]. Over 75 formulations are readily available in the Indian market for health and vitality; all contain Withania somnifera (100%), Asparagus racemosus (81.5%), A. adscendens (48%) and Curculigo orchioides (15 %), with other plants in small proportions [25]. The plants Glycirrhiza glabra, Piper longum, Adhatoda vasica , W. somnifera , Ciprus rotundus, Tinospora cordifolia, Berberis aristata, Tribulus terrestris, Holarrhena antidysenterica and Boerhavia diffusa are used in approximattely 140 herbal formulations. Triphala containing potent anticancer agents (Terminalia chebula, T. bellerica and Embelica officinalis ) has been found in more than 219 formulations [26]. Some of the formulations that are widely used in treatment of cancer are listed in (Table 1).

S.No Name of formulation Name of herbal plants
1. United States Patent 6780441 Sahajanand Biotech Private Limited (Gujarat, IN) Withania somnifera, Chlorphyton borivilianum, Boerhavia diffusa, Elephantopus scaber, Moringa oleifera, Tecoma undulata, Bauhinia purpurea, Ficus racemosa, Cyperus rotundus, Sphaeranthus acmella and Tinospora cordifolia.
2. Immunotone
Sino-Vedic Cancer Research Centre
Immunotone herbal formulation contains active princples isolated from selected antimutagenic and immunoenhancing herbs such as Aegle marmelos,Aloe vera, Alpinia galanga, Andrographis paniculata, Azadirachta indica, Berberis vulgaris, Curcuma domestica, Emblica officinalis, Glycine max, Morinda citrifolia, Ocimum sanctum, Tinospora cordifolia, Trigonella foenum-graecum, Viscum album, Withania somnifera and Zingiber officinale.
3. Cancertame
Sino-Vedic Cancer Research Centre
Cancertame herbal formulation contains active principles isolated from Bauhinia variegata, Catharanthus roseus, Curcuma longa, Glycine max, Glycyrrhiza glabra, Gossypium hirsutum, Nigella sativa, Phyllanthus emblica, Plumbago zeylanica, Rubia cordifolia, Solanum indicum, Zingiber officinale, Aloe vera, Amoora rohituka and Azadirachta indica.
4. Oncotame
Sino-Vedic Cancer Research Centre
Oncotame herbal formulation contains active princples isolated from Ginkgo biloba, Oldenlandia diffusa, Podophyllum emodi, Prunella vulgaris, Psoralea corylifolia, Saussurea lappa, Solanum nigrum, Withania somnifera, Panax ginseng, Catharanthus alba, Curcuma aromatica, Andrographis paniculata, Aloe barbadensis, Emblica officinalis and Viscum album.
5. Chen Pi
Ageless Herbs
Citris reticulate, Astragalus membranaceus, Arctium lappa, Ganoderma lucidum, Trifolium pretense, Eleutherococcus senticosus, Rumex crispus, Atractylodes macrocephala, Spatholobus suberectus, Ascophyllum nodosum, Prunella Vulgaris, Salvia miltiorrhiza, Carthamus tinctorius, Rumex acetosella, Foeniculum vulgare, Althaea officinalis.
6. Caractol Blepharis Edulis, Piper Cubeba Linn, Smilax China Linn, Hemidesmus Indicus, Tribulus Terrestris, Ammania Vesieatoria, Lepidium Sativum Linn, Rheum emodi wall.
7. Triphala Terminalia chebula, Embelica officinalis, Terminalia bellerica.
8. Vidakana choornam Embelia ribes, Mrigna oleifera, piper longum
9. Liv 52 Capparis spinosa, Cichorium intybus,Mandur bhasma, Solanum nigrum, Terminalia arjuna, Cassia occidentalis, Achilea millefolium, Tamarix gallica 
10. Immu-21 Ocimum sanctum, Withania somnifera, Emblica officinalis and Tinospora cordifolia

Table 1: List of Herbal formulations available in the market for cancer treatment [73-75]

Modern drug discovery process is primarily driven by tracing the traditional medicinal use followed by bioactivity guided fractionation to identify major active ingredients.

In recent decades, versatile analytical techniques have emerged and became readily available to aid the quest for rapid discovery of bioactive compounds. Isolation, identification and characterization of bioactive compounds from medicinal plants is currently a major scientific theme in many research laboratories around the globe. Modern instrumental techniques, such as, mass spectrometry and nuclear magnetic resonance spectroscopy play a major role in the identification, characterization and classification of novel bioactive molecules.

Phytochemicals including alkaloids, carotenoids, phenolics, organo sulfur compounds, non-protein amino acids, saponins, flavonoids and several other molecules with pharmacalogically important activities have been isolated from Ayurvedic herbs [27]. For example, flavonoids such as apigenin and quercetin, have been shown to inhibit melanoma cancer cell lines and metastasis [28]. Research directed towards the identification of agents capable of inhibiting lung colonization revealed that, many polyphenols have the ability to decrease the number of B16- BL6 colonies in lung in a dose-dependent manner [28]. Structures of several anticancer agents derived from Ayurvedic medicinal plants are provided in (Figure 2).

molecular-pharmaceutics-organic-therapeutic-agents

Figure 2: Molecular structures of selective therapeutic agents derived from Ayurvedic medicinal plants.

Typically, fruits, vegetables, herbs, and spices containing isothiocyanate, curcumin, genistein, epigallocatechin gallate, lycopene, resveratrol and several other bioactive phytochemicals are consumed as part of regular diet [29] that act as chemotherapeutic agents.

Many plant derived compounds are available in the market and are produced on commercial scale by pharmaceutical companies (Table 2) [30].

S.No Plant species
Botanical name (local name)
Active molecules/plant extracts Biological anti-cancer activities against
1 Andrographis paniculata Nees (Green chirayta) Andrographolide, neoandrographolide and dehydroandrographolide B16F0 melanoma syngenic and HT-29 xenograft models[47] , 2-cell line panel containing MCF-7 (breast cancer cell line) and HCT-116 (colon cancer cell line)[49], multiple myeloma [50,51], rats induced with gastric ulcer [52]
2 Alpinia galangal Willd (Greater galangal) 1’S-1’-acetoxychavicol acetate, 1,8-cineole, beta- bisaboline and beta- seline, Galangin and Camphor COR L23 cells (lung cancer cell line) and MCF7 cells (breast cancer cell line) with IC50 7.8uM and 23.9uM[76]
4 Aristolochia indica(Birthwort) Aristolochic Acid Cytotoxic against Chinese hamster ovary-K1 ( CHO-K1) cells [77]
5 Agati grandiflora(Humming bird tree) Whole plant material ethanol extract Anticancer effect against Ehrlich Ascites Carcinoma (EAC) in mice cell line [78]
6 Albizzia lebbeck(Rain tree) triterpenoid saponins [79] Antitumor activity against gall tumors [80]
7 Allium sativum (Garlic) Abstract Diallyl sulfide[81], S-allylcysteine, S-allymercaptol-cysteine Cytotoxic against colorectal adeno carcinoma [81]
8 Aloe vera (Aloe) Barbaloin (aloe-emodin, aloesin, aloin), acemannan Selectively inhibited the growth of human neuroectodermal tumors in mice[82], caused tumor shrinkage, tumor necrosis and lymphocytic infiltration in dogs [83]
9 Alstonia scholarisLinn (Milky pine, sapthaparna) ethanol extract (Echitamine[84]) Selectively inhibited the forestomach carcinogenesis in mice[85]
10 Amorphopallus campanulatus(Elephant foot yam) Methalonic extract Cytotoxic and apoptotic activities against human hepatoma cell line [86], against human colon carcinoma cell line HCT-15[86]
11 Amoora rohituka(Rohituka tree) Petroleum ether extract Cytotoxic effects on breast and pancreatic cnacer cells[87]
12 Azadirachta indica(The wonder tree) Nimbolide[88] Antiproliferative effect on human cancel lines[88]
13 Bacopa monnieri(Indian penny wort) bacoside A and B[89]stigmasterol [90] Antitumor against Ehrlich Ascites carcinoma in mice[90]
14 Berberis aristate(Indian ophthalmic barberry) Methanolic extract Cytotoxic activity in MCF7 cell line [91]
15 Calotropis gigantea R. Br(Gigantic swallow wort) Alcoholic extract, Lupeol Anti-cervical cancer activity [92]
16 Calotropis procera R. Br(Crown floer) Asclepin, Alcoholic extract Antiproliferative activity [93]
17 Cassia fistula(Golden shower tree) Methanolic extract Antitumor activities against Ehrlich ascites carcinoma [94]
18 Carum roxburghianum Kurz(Azowan) Monoterpene hydrocarbon Cytotoxic in the brine shrimp lethality assays [95]
19 Corallocarpus epigaeus (Onion) Methanolic extract Cytotoxic activity against human breast adenocarcinoma (MCF7) and human colon carcinoma (HT-29) [96]
20 Crataeva nurvala(Three leaces caper) Methanol extract, Lupeol[97] Cytotoxic activity in brine shrimp lethality bioassay [98]
21 Curcuma longa(Tumeric) Curcumin I-III [43,99] Potent inhibitor of Loekotriene B4 formation in rat peritoneal polymorphonuclear neutrophils (PMNL) [43,99]
22 Curcuma zedoaria(White turmeric) Curcuminoids [100]
Isocurcumenol [101]
Cytotoxic against human ovarian cancer OVCAR-3 cells [100]
23 Cymbopogon citrates(Lemongrass) Citral [102] Induced apoptosis in caspase-3 enzymatic activity
24 Cinnamomum cassia(Cinnamon bark) Aqueous extract, 2'-Hydroxycinnamaldehyde (HCA)[103] Induced apoptosis in human cervical cancer line (SiHa) [104]
25 Datura metel L.(Angel’s trumpet) Withanolides [105]
daturametelins H–J [106]
Cytotoxic activities agains A549 (lung), BGC-823 (gastric) and K562 (leukemia) cancer cell lines [105]
26 Euphorbia neriifolia L(Indain spurge tree) Hydro-ethanolic extract Chemopreventive effect against DENA-induced renal carcinogenesis in mice [107]
27 Elephantopus scaber(Elephant’s foot) Deoxyelephantopin (ESD)
[108]
Elescaberin, isodeoxyelephantopin,
Deoxyelephantopin [109,110]
Antineoplastic effects of a sesquiterpene lactone on lung adenocarcinoma (A549) cells [109,110]
28 Ficus glomerata(Goolar fig) Ethanolic extract Anticancer activities in mammary carcinoma DMBA induced rats [111]
29 Madhuca indica(Butter tree) Ethanolic extract Cytotoxicity against ling (A-549), colon (502713 HT-29) and neuroblastima (IMR-32) cell line [112]
30 Mallotus philippinensis Muell. Arg (Kamala tree) 3alpha-hydroxy-D:A-friedooleanan-2-one [113], Ethanolic extract with
Rottlerin [114,115]
Cytotoxic activity on human cancer cell lines [116]
31 Saraca indica(Ashoka tree) 7,12-dimethyl benz(a)anthracene [117] Chemopreventive property in skin cancer in mice models [117]
32 Emblica officinalis,Gaertn, pyrogallol [118]7, 12-dimethyabenz(a)anthrecene [119] Cyclophosphamide (CP) [120] Chemopreventive property on DMBA induced skin tumorigenesis in Swiss albino mice [119]
33 Urginea indica (Indian squill/ wild onion) 29k Da glycoprotein[121] Antitumor activity against ascites tumor, mouse mammary carcinoma [121]
34 Taxus buccata(Himalyan yew) Taxol[122], taxotere Cytotoxic against breast, lung, ovarian, colorectal cancer and melanoma tumor colony [123]
35 Withania somnifera(Indian ginseng)[124] Withaferin A[55]
Viscosalactone B[59]
Antitumor activity on S-180 in BALB/c mice [124], antiproliferative activity on NCL-H460 (lung), HCT-116 (colon), SF-268 (central nervous system;CNS and MCF-7(breast) human tumor cell lines [59]
36 Xantium strumarium(Burdock datura)[125] Xanthatin and xanthinosin[126] Cytotoxicity in the human cancer cell lines WiDr ATCC (colon), MDA-MB-231 ATCC (breast) and NCI-417 (lung) [126], Cytotoxic effects on the human cell line, HL-60 [127]

Table 2: List of pharmaceutical drug leads derived from Ayurvedic medicinal plants.

Several molecules derived from plants with Ayurvedic importance are the lead compounds for important drugs that are being used to treat cancer and immune related diseases. For example; taxol, roscovitine, combretastatin A-4, betulinic acid, silvestrol, camptothecin, podophyllotoxin, topotecan, irintecan, vincristine, vinblastin and flavopiridol are some of the potential drug leads in the treatment of different cancer types [30].

Taxanes are unique class of anticancer agents that exert cytotoxic activity againt cancer cells with specific mechanism. Many Taxus species have been claimed to be used in treatment of cancer in Ayurveda practices and also by Native American tribes. Paclitaxel (Taxol) is the first taxane anticancer drug, isolated from bark of Taxus brevifolia (Pacific yew), received regulatory approval in many countries for ovarian and breast cancer treatment [31]. Subsequently, paclitaxel and many other precursors have been reported in many Taxus species. Furthermore, 23 taxanes are in preclinical trials for treatment of cancer [32]. In recent years, paclitaxel has attracted attention in treatmet of multiple sclerosis, psoriasis and rheumatoid arthritis [33].

Flavopiridol (alvocidib) is a semisynthetic flavonoid precursor of rohitukine extracted from Dysoxylum binectariferum [34], widely used in Ayurvedic medicine. Flavopiridol showed significant inhibition against cyclin-dependent kinase CDK 1, CDK 2,CDK 4 and CDK 7 [34,35]. Due to its exceptional ability to suppress lung carcinoma, breast cancer carcinoma, multiple myeloa and head and neck squamous cell carcinoma, this molecule has entered into clinical trials. More than 60 clinical trials (Phase I and II) have been carried out between years 1998- 2014 [36,37]. Despite its potent in vitro activities and extensive investment in these trials, there are no Phase III studies reported [38] to date.

Curcumin is a hydrophobic polyphenol compound derived from curcuma longa, commonly known as turmeric is consumed in regular culinary [39]. Traditionally, turmeric is commonly used in the treatment of microbial diseases, stomach and liver ailments. Phytochemical evaluation of turmeric revealed two major constituents demethoxycurcumin (DMC) and bisdemethoxycurcumin (BDMC), apart from curcumin [40]. In vitro and in vivo studies have demonstrated that curcumin is a potent anti-tumorigenic agent [41,42] against different cancer types including colon, skin, duodenum and stomach. Curcumin is considered as noble chemopreventive and antitumor agent with its multiple targeting property without side effects even at high dose [41-43].

On the contrary, poor bioavailability, solubility and absorption hindered its approval as chemotherapeutic agent [39]. Recent studies showed that curcumin posses in vitro anti-angiogenic and in vivo antitumor properties through combined phosphodiesterases- PDE2 and PDE3 inhibition [44]. Furthermore, DMC induced the expression of promoter of methylated genes more than cumin in leukemia cells and on combination could give optimum re-expression of epigenetically silenced genes [45,46]. The ongoing research outcomes provide strong indication that curcumin will be a potenail anticancer chemotherapy agent derived from Ayurvedic herb.

Andrographis paniculata Nees commonly known as ‘King of Bitters’ (Kalmeg ) in Ayurveda [47]. Kalmeg is distributed throughout South India and Srilanka displayed broad spectrum of activities including anticarcinogenic, anti HIV and several other pharmacological activities [47]. Pharmaceutical constituents including andrographolide, neoandrographolide and dehydroandrographolide have been shown to possess anti-cancer properties [48]. Andrographolide being most active compound from kalmeg has shown anticancer properties in several in vitro and in vivo studies against B16F0 melanoma syngeneic and HT-29 xenograft models [47] , 2-cell line panel containing MCF-7 (breast cancer cell line) and HCT-116 (colon cancer cell line)[49], multiple myeloma [50,51], rats induced with gastric ulcer [52]. In one of the human study commenced by Darryl and co-authors, ingestion of A. paniculata at a dose of 500 mg twice daily along with other nutraceuticals by 20 patients with late stage cancer in different parts showed significant improvement in the patients [53]. However, the poor oral biovailability has remained a major setback [54].

Withania somnifera is commonly known as “Ashwagandha”, widely used in Ayurveda for treatment of arthritis, menstrual cycle and uterus related disorders, cancer and other inflammatory diseases [55]. Previous in vivo studies demonstrated antitumor properties of roots of Aswagandha against Sarcoma-180 solid tumor with low toxicity [56]. Withaferin A is a most abundant bioactive constituent of W. somnifera and received a marked interest globally for its exceptional anticancer and anti-inflammatory properties [57].

Withaferin A inhibits Notch-1 signalling and down regulates pro survival pathways such as Akt/NF-kB/Bcl-2, in HCT-116, SW-480 and SW-620 cancer cell lines [58]. Also other in vivo studies suggest antiproliferative activity on NCL-H460 (lung), HCT-116 (colon), SF-268 (central nervous system; CNS and MCF-7 (breast) human tumor cell lines [59]. Recent studies conducted by Li Xu and coauthors [60] suggest the synergistic antitumor activity of withaferin A combined with oxaliplatin.

Withaferin A enhanced oxaliplatin induced growth suppression and apoptosis in PC cells via mitochondrial dysfunction and inactivation of the P13K/AKT pathway [60]. Withaferin A is of particular interst due to its ability to interact and inhibit different cancer-specific pathways with least toxic effects.

Market share of Ayurvedic medicine in the pharmaceutical industry

Natural products derived from plants, animals and other sources have been pivotal in treatment of human diseases. Ayurvedic medicine has significant history in this respect and there is an ongoing demand due to their efficacy, low toxicity and fewer side effects. These positive attributes have led to mushrooming of Ayurvedic medical practices and related herbal based drug manufacturing companies worldwide.

The market value for Ayurvedic herbs and their derivatives is growing annually at 20% and the sales have increased by 25% in the last 10 years. To date, China and India are major sources of herbal products. In the global market, China shares 13% of total market whereas India shares only 2.5% [61]. Remarkably, Traditional Chinese medicinal (TCM) system comprises 5000 plant species while Ayurvedic medicinal system uses 7000 plant species [62]. According to Export / Import Bank, TCM plants have a global trade value of US $6 billion, while Ayurvedic medicine have only a share of US $1 billion. The trade of Ayurvedic products are expected to increase rapidly in the near future, due to the fact that a number of dugs with high efficacy are primarily derived by the utilization of realm of traditional Ayurvedic knowledge.

The trade of Ayurvedic medicine is mainly being affected by poor quality control practices, lack of efficient agricultural practices, lack of knowledge on the global marketing strategies and standardization of processes and services. The projection made by WHO states that the global herbal market would grow to $5 trillion by 2050 from the current market level of $62 billion [61]. The effort from ‘different associations like National Medicinal Plants Board (NMPB), Department of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy (AYUSH), World Health organization (WHO) in India, USA, UK, Russia, Germany, Hungary and South Africa are now yielding good results in promoting Ayurveda which has opened-up new opportunities [63].

Implications of using Ayurvedic medicine

Ayurvedic medicine system is a very ancient and is now practiced throughout the world. The Ayurvedic medicine preparations are formulated by a combination of medicinal plants, animal products and minerals and metals including gold, copper, lead, mercury, iron and zinc [64]. These metals are primarily added to herbal products as ashes or bhasmas, with a belief that they act as catalyst and improves the target specificity. However, Ayurvedic practioners often prescribe medicine which do not meet the criteria of modern GMP or manufactured by practitioners themselves. According to Centre for Disease Control, during the years between 2000 – 2003, 12 cases were reported with lead toxication after consumption of Ayurvedic products [65]. Strict regulations for Ayurvedic preparations are therefore expected to minimize adverse effects and improve the acceptance of these medicine by global communities.

Many herbal supplements that are available in the market are subjected to limited regulations. Individuals consume these herbal products as dietary supplements without proper knowledge of pros and cons and hence often affected by toxic effects. In a case study of a 69-year-old Caucasian male retired lawyer consumed ‘Bhasma’ an ayurvedic herbal medication on family advice while traveling in India. He reported illness of being lethargy, fatigue, memory impairment, generalized weakness, severe constipation, anorexia and weight loss of 18 kg over preceding eight months. After thorough clinical investigations, discontinuation of Ayurvedic Bhasmas and chelation therapy treatment helped him to recover from these issues [66].

Chemical constituents of plants can be influenced by several factors including habitat, cultivation site, seasonal variations, temperature, soil composition, water availability and pollutant levels in the atmosphere. Furthermore, physicians prescribe different plant species for specific symptoms due to morphological similarities. For instance, Shankhpushpi is herbal drug widely used in the treatment of epilepsy, leucoderma, bronchitis and teething problems. This drug is sourced from three plant species, namely, Clitoria ternatea , Convolvulus pluricaulis and Evolvulus alsinoides in different regions of the country [67]. In fact, the chemical consitutents of these plants are significantly distinct from one another. Due to ever increasing demand for Shankhpushpi and other important herbal products, the preparations are often altered with other plant material. Phytochemical investigations suggest that over 60 % herbal products available in the market are adulterated [68].

In order to supply quality herbral products for better health, there is a requirement of standardized authentication of herbs. For instance, rigourous morphological analysis and quantification of molecular markers can be used as an effective means of identification of plants. It is therefore essential that the regulations on authentication of plant material must be strictly implemented in order to minimize adverse effects due to adultration of herbal medicine and also to gain the desired health benefits.

Interface between Ayurveda and modern medicine

In the realm of moder drug discovery, traditional knowledge of Ayurvedic medicinal plants is playing pivotal role. There has been significant correlation between the use of herbs for particular symptoms and the targets of derived drugs. Anticancer drugs derived from Ayurvedic medicinal plants exert their activity by means of activation or inactivation of signaling pathways [69]. Oncogenes, cancer growth factors, cancer promoting enzymes, protein kinases have been identified as major targets in drug discovery and development process [70]. Thousands of years ago, Ayurvedic medicinal system used many medicinal plants in the treatment of cancer (when there was no modern medicinal knowedge existed). Drugs derived from many of these traditional plants are now well established inhibitors of the targets responsible for different cancers. For instance, Vinca rosea and Taxus species were widely used in the treatment of different cancer types [71]. Vincristine and paclitaxel isolated from these plants showed strong anticancer properties. [71]. These compounds are now available in the drug market.

Modern cancer treatment typically involves administration of a single therapeutic agents into human system. These agents usually lack specificity to the target or multiple targets, leads to apoptosis of healthy cells and causes adverse side effects. Toxicity and side effects remained to be major setbacks in chemotherapeutic approaches to cancer treatment. For example, anticancer drugs, including vincristine and paclitaxel, are responsible for peripheral neuropathy during cancer treatment [71].

Typical Ayurveda treatment involes adminstration of an individual or mixture of different plant extracts. Ayurveda recommends formulation (multiple plants at different proportions) to obtain synergism and diminish drug associated side effects such as cachexia (including nausea, wait loass and anorexia). For instance, W. sominifera, Sida cordifolia, Vitis vinifera, Plumbago zeylanci, Tinospora cordifolia Asparagus racemosa and Zingiber officinale are often used to improve apetite, malnutrition, body resistance and fatigue. In addition, Ayurvedic treatment incorporates yoga and relaxation therapies which provide spiritual well-being of the patient. The effectiveness of these holistic approaches goes beyond the symptom relief and improves physiological and behavioral aspects of the patient.

Owing to these benefits. modern cancer treatments are gradually adapting combinatorial approaches including yoga, meditation, mindpositive thinking and cognitive practices along with chemotherapy. The case of Anita Moorjani’s experience with lymphoma evidences role of mind and positive thinking in curing diseases[72]. Anita underwent many conventional chemotherapy cancer treatments. During the cancer treatment she fell into deep coma for several days and claimed to have had near death experience and out-of-body experience [72]. As the lymphoma had metastasized throughout her body and her death was confirmed. Subsequently, Anita cam e out of coma surviving from cancer, claiming that it was only possible through spontaneous healing developed from positive thinking attitude [33]. Meditation, yoga and prayers have been practiced in Ayurvedic treatment to develop mindbody control [33]. Furthermore, a study conducted by Özlem Ülger and co-authors evidednced improved health conditions in cancer patients after yoga practices [65]. These observations suggest that a revolutionized approach can be devised through integration of Ayurvedic practices with modern day treatments for enhanced efficacy of cancer therapies.

Conclusion

The quest for pharmaceutical drug leads from Ayurvedic medicinal plants has been rapidly growing. The prime reason for this interest is: medicinal plants are cost effective, reliable and posses least side effects. However, ever growing requirement of medicinal plants often leads to cultivation of malpractices. In this respect, educating the communities about correct procedures of collecting, extracting, handling and storing of herbal material, and strict implementation of regulations on quality control would minimize wrong practices and improve the grade of the products and their efficiency. Furthermore, the toxicity and safety assessment procedures for these herbal medicines should be conducted using modern analytical techniques and tools for their improved efficacy. Many international authorities and agencies including the WHO, European Agency for the Evaluation of Medicinal Products and European Scientific Cooperation of Phytomedicine, US Agency for Health Care Policy and Research, European Pharmacopeia Commission and the Department of Indian System of Medicine have initiated developing and implementing new and effective strategies for regulating quality control and standardization of herbal medicine. In addition, appropriate global marketing strategies would boost the usage and economic value of Ayurvedic medicinal plants.

References

Citation: Bhandari M, Ravipati AS, Reddy N, Koyyalamudi SR (2015) Traditional Ayurvedic medicines: Pathway to develop anti-cancer drugs. J Mol Pharm Org Process Res 3: 130. Doi: 10.4172/2329-9053.1000130

Copyright: ©2015 Koyyalamudi SR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Recommended Conferences
Article Usage
  • Total views: 22048
  • [From(publication date): 12-2015 - Aug 12, 2020]
  • Breakdown by view type
  • HTML page views: 21170
  • PDF downloads: 878
Share This Article
Top